What Is Lineage Cell Therapeutics Doing To Tackle COVID-19?
Source: Life Science Leader
Rob Wright, chief editor of Life Science Leader, conducted a virtual roundtable with four CEOs and company founders (view full video here). In this segment, Brian Culley, CEO of Lineage Cell Therapeutics, discusses how his company’s expertise in dendritic cells could prove beneficial in developing and delivering a “super vaccine” for COVID-19.
This website uses cookies to ensure you get the best experience on our website. Learn more